NYSE •
Healthcare •
Biotechnology •
Quote as of 08/07/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization13.03 mln
Float6.93 mln
Earnings Date08/18/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
83
/ 100
Strongly outperforming
Debt / Equity
-0.16
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
AEON Biopharma is a California-based medical company working to bring new treatments to patients suffering from serious and often overlooked conditions. Its main focus is a drug called prabotulinumtoxinA, a form of botulinum toxin being studied for conditions such as cervical dystonia, chronic migraine, gastroparesis, and post-traumatic stress disorder. The company operates through partnerships with Daewoong Pharmaceutical and Viatris to advance its clinical programs.
